VIX Short-Term Futures ETN Ipath (VXX) 25.73 $VXX Weekly

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VIX Short-Term Futures ETN Ipath (VXX) 25.73 $VXX

Weekly ETF Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 3:12PM CDT

VNM: 17.67 (+0.22), USO: 16.43 (+0.35), GDXJ: 24.10 (+0.88), VXX: 25.73 (-0.40), OIL: 9.79 (+0.22), SIVR: 16.44 (+0.56), SLV: 16.00 (+0.56), GDX: 19.33 (+0.62), EWZ: 31.54 (+1.32), UUP: 25.82 (-0.35)

Investors Should Stick With Health Care Stocks, eBay Has Downside
at The Street - Thu Mar 19, 1:56PM CDT
The CNBC ‘Fast Money Halftime’ trading panel agrees that health care stocks still have an upside, while an analyst explains his decision to downgrade eBay.
KMI: 42.12 (+0.59), BIIB: 475.98 (+42.33), MNST: 137.52 (-0.76), EWG: 30.26 (+0.79), VXX: 25.73 (-0.40), NKE: 101.98 (+3.66), UNH: 119.14 (-1.62), KORS: 66.13 (-0.69), TLT: 131.51 (+0.69), GOOG: 560.36 (+2.37), COH: 41.58 (+0.32), SPY: 210.41 (+0.91), EBAY: 57.93 (+0.05), DIA: 180.96 (+1.30), GOOGL: 564.95 (+1.28), FL: 62.70 (+0.62), FXE: 106.32 (+1.63), AAPL: 125.90 (-1.60), FB: 83.80 (+1.05), TIF: 82.93 (-3.44), XLU: 44.98 (+0.05), UUP: 25.82 (-0.35), XRT: 100.96 (+0.28), ARO: 3.14 (+0.12), XLV: 74.90 (+0.33), CELG: 128.50 (+3.17), GES: 18.84 (-0.58), UA: 81.43 (+0.42), QQQ: 108.53 (+0.45), BONT: 6.40 (-0.08), GILD: 102.29 (+0.85), CRI: 93.89 (+2.18), IWM: 125.99 (+1.10)

iPATH S&P 500 VIX Short-Term Futures ETN Down 13.8% Since SmarTrend Downtrend Call (VXX)
Comtex SmarTrend(R) - Thu Mar 19, 9:42AM CDT
SmarTrend identified a Downtrend for iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) on February 19th, 2015 at $30.61. In approximately 4 weeks, iPATH S&P 500 VIX Short-Term Futures ETN has returned 13.80% as of today's recent price of $26.38.
VXX: 25.73 (-0.40)

Long VIX ETPs seeing lots of action ahead of FOMC
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 12:33PM CDT

TVIZ: 18.95 (-0.28), TVIX: 1.73 (-0.06), XVZ: 28.51 (+0.20), VIXM: 60.81 (+0.37), XVIX: 16.69 (+0.26), ZIV: 42.37 (-0.25), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), VIIX: 34.73 (-0.55), CVOL: 0.79 (unch), VXZ: 12.49 (+0.07), VIIZ: 17.14 (+0.03), XXV: 38.28 (+0.02), SVXY: 67.98 (+1.12), XIV: 34.63 (+0.54), VIXY: 17.10 (-0.28)

March Madness - Dividend Grandness And Volatility Blandness
Wade Slome, CFA - at Seeking Alpha - Tue Mar 17, 12:37AM CDT
March Madness has arrived once again. This NCAA basketball event, which has been around since 1939, begins with a selection committee choosing the top 68 teams in the country. These teams are matched up against each other through a single-elimination...
TVIZ: 18.95 (-0.28), TVIX: 1.73 (-0.06), VIXM: 60.81 (+0.37), XVIX: 16.69 (+0.26), VXX: 25.73 (-0.40), IVOP: 38.01 (+0.13), UVXY: 15.26 (-0.46), CVOL: 0.79 (unch), VXZ: 12.49 (+0.07), XIV: 34.63 (+0.54), SVXY: 67.98 (+1.12), XVZ: 28.51 (+0.20), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), ZIV: 42.37 (-0.25), DIA: 180.96 (+1.30), VIIX: 34.73 (-0.55), VIIZ: 17.14 (+0.03), XXV: 38.28 (+0.02), VIXY: 17.10 (-0.28)

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Rebound After Yesterday's Selloff of 2.46%
Comtex SmarTrend(R) - Mon Mar 16, 3:55PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.15 to a high of $27.82. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $27.40 on volume of 33.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 25.73 (-0.40)

After Yesterday's Decline of 2.46%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Mar 16, 3:54PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.15 to a high of $27.82. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $27.40 on volume of 33.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VXX: 25.73 (-0.40)

Stocks Rally Despite Fall in Crude Prices, but Don’t Be So Quick to Sell Disney
at The Street - Mon Mar 16, 2:33PM CDT
The CNBC 'Fast Money Halftime' trading panel analyzes stocks following crude oil's new five-year low and speaks with the analyst who downgraded Disney.
USO: 16.43 (+0.35), EWG: 30.26 (+0.79), UCO: 6.50 (+0.26), VXX: 25.73 (-0.40), OIH: 33.30 (+0.74), XOP: 48.19 (+0.22), XOM: 84.54 (+0.13), DIS: 108.43 (+1.06), TLT: 131.51 (+0.69), SLB: 82.37 (+1.36), NFLX: 428.30 (+3.09), VLO: 61.55 (+0.75), SPY: 210.41 (+0.91), FOX: 34.40 (+0.82), QQQ: 108.53 (+0.45), TSO: 93.51 (+0.42), DIA: 180.96 (+1.30), IWM: 125.99 (+1.10), MRO: 26.18 (+0.49), CVX: 107.03 (+2.28), XLE: 76.91 (+0.60), APC: 81.95 (+1.52), BHI: 62.47 (+1.54)

Market Outlook - Between A Rock And A Hard Place
Price Headley, CFA - at Seeking Alpha - Mon Mar 16, 12:47AM CDT
The third weekly loss in a row has brought the broad market down 2.4% from its recent peak. In the grand scheme of things, it's not much... not even enough to call a full corrective move. Even so, there are glimmers of hope that the selloff has run...
SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), VXX: 25.73 (-0.40), GLD: 113.57 (+1.28), DIA: 180.96 (+1.30), IWM: 125.99 (+1.10), UUP: 25.82 (-0.35)

Lessons From Another Tough Week And The Big Day Ahead
Eric Parnell, CFA - at Seeking Alpha - Sat Mar 14, 9:24AM CDT

XLB: 49.23 (+0.13), VXX: 25.73 (-0.40), EWL: 34.00 (+0.71), TLT: 131.51 (+0.69), EWJ: 12.81 (+0.20), HEDJ: 66.87 (+0.74), EEM: 40.08 (+0.59), KRE: 41.38 (+0.48), FXB: 146.71 (+2.18), OIL: 9.79 (+0.22), XLK: 42.54 (+0.10), FXC: 79.03 (+0.88), FXE: 106.32 (+1.63), EMB: 111.69 (+1.20), SLV: 16.00 (+0.56), XLF: 24.71 (+0.24), VNQ: 87.03 (+2.13), FXF: 99.75 (+1.49), JJC: 33.04 (+1.20), XLE: 76.91 (+0.60), HYG: 90.44 (+0.70), MUB: 110.47 (-0.03), FXY: 80.98 (+0.65), EZU: 39.08 (+1.08), XLU: 44.98 (+0.05), UUP: 25.82 (-0.35), XRT: 100.96 (+0.28), FXS: 116.66 (+2.56), XLV: 74.90 (+0.33), GSG: 19.51 (+0.25), PCY: 28.30 (+0.29), EWU: 18.82 (+0.43), GLD: 113.57 (+1.28), PFF: 40.05 (+0.14), IWM: 125.99 (+1.10)

Weak Euro, Strong Dollar, Investors Fret on Forex Impact on Earnings
at The Street - Fri Mar 13, 1:15PM CDT
CNBC’s ‘Fast Money Halftime’ traders analyze the continued strength of the U.S. dollar and hear from the founder of Lumber Liquidators.
EWG: 30.26 (+0.79), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), VXX: 25.73 (-0.40), EWU: 18.82 (+0.43), TGT: 81.31 (+0.71), EWQ: 26.42 (+0.70), DIA: 180.96 (+1.30), LOCO: 27.00 (+1.11), EWGS: 40.17 (+0.98), LL: 28.51 (-0.84), IWM: 125.99 (+1.10), TLT: 131.51 (+0.69), HEWG: 28.80 (+0.33)

Today's Market - Why Poor Retail Sales News Is Good News For Stocks
Markos Kaminis - at Seeking Alpha - Thu Mar 12, 10:11AM CDT

SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), VXX: 25.73 (-0.40), DIA: 180.96 (+1.30), IWM: 125.99 (+1.10), INTC: 31.31 (+0.57)

Stock Market Correction Of 10% Or More? Why It's Very Likely
Markos Kaminis - at Seeking Alpha - Wed Mar 11, 11:30PM CDT

VTI: 109.76 (+0.91), JNK: 39.13 (+0.28), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), VXX: 25.73 (-0.40), GLD: 113.57 (+1.28), OIL: 9.79 (+0.22), DIA: 180.96 (+1.30), PG: 84.74 (+1.36), IWM: 125.99 (+1.10)

VXX - Our Short Captured 15% In 1 Month, But Volatility Is Back
Markos Kaminis - at Seeking Alpha - Wed Mar 11, 7:28PM CDT

TVIX: 1.73 (-0.06), SPY: 210.41 (+0.91), VXX: 25.73 (-0.40), UVXY: 15.26 (-0.46), XIV: 34.63 (+0.54)

Beware Chasing QE
Eric Parnell, CFA - at Seeking Alpha - Wed Mar 11, 1:12PM CDT

EWG: 30.26 (+0.79), VXX: 25.73 (-0.40), EWQ: 26.42 (+0.70), FXY: 80.98 (+0.65), EWP: 34.42 (+1.53), EZU: 39.08 (+1.08), XLU: 44.98 (+0.05), TLT: 131.51 (+0.69), EWJ: 12.81 (+0.20), DXJ: 56.03 (+0.41), HEDJ: 66.87 (+0.74), SPY: 210.41 (+0.91), PFF: 40.05 (+0.14), FXE: 106.32 (+1.63), VNQ: 87.03 (+2.13), SDY: 79.11 (+0.43)

An Age Is Ending
Harry Long - at Seeking Alpha - Wed Mar 11, 9:26AM CDT

VXX: 25.73 (-0.40), VIXY: 17.10 (-0.28)

After Yesterday's Rally of 3.07% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Mar 10, 3:53PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $28.24 to a high of $28.91. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $28.20 on volume of 47.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VXX: 25.73 (-0.40)

iPATH S&P 500 VIX Short-Term Futures ETN Rises 3.07% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Mar 10, 3:53PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $28.24 to a high of $28.91. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $28.20 on volume of 47.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VXX: 25.73 (-0.40)

Mick McGuire: Bank of New York Mellon Should Replace Its CEO
at The Street - Tue Mar 10, 1:30PM CDT
The CNBC ‘Fast Money Halftime’ trading panel discussed Tuesday’s selloff and whether Bank of New York Mellon needs a new CEO.
BID: 42.28 (+0.61), EWG: 30.26 (+0.79), VXX: 25.73 (-0.40), EWQ: 26.42 (+0.70), INTC: 31.31 (+0.57), DXJS: 34.39 (+0.42), TLT: 131.51 (+0.69), HEWG: 28.80 (+0.33), IMAX: 34.54 (-0.02), DXJ: 56.03 (+0.41), SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), EWU: 18.82 (+0.43), DE: 89.18 (+1.10), DIA: 180.96 (+1.30), EWGS: 40.17 (+0.98), IWM: 125.99 (+1.10), XLF: 24.71 (+0.24), BK: 40.57 (+0.27)

Market Outlook - Will Friday's Sell-Off Have Legs?
Price Headley, CFA - Seeking Alpha - Mon Mar 09, 7:28AM CDT
Though it wasn't necessarily a bullish week, the market was holding up well enough... until Friday's implosion. That one bad day pulled the market under some key support levels, and as such we now have to entertain the possibility that some selling...
SPY: 210.41 (+0.91), QQQ: 108.53 (+0.45), VXX: 25.73 (-0.40), DIA: 180.96 (+1.30), IWM: 125.99 (+1.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

CeraVe Marks 20 Years of Groundbreaking Skincare Innovations

Updated Category News Views 259

CeraVe's Celebrated Journey in Skincare CeraVe is making waves as it marks an impressive milestone: 20 years of dedicated skincare science. Launching with the mission to nurture and restore skin health, the brand has garnered an extensive following of both customers and dermatology professionals worldwide. By focusing on skin barrier health and utilizing innovative...

Continue Reading
Exploring Novartis' Latest Innovations in Hematology and Oncology

Updated Category News Views 320

Novartis Pioneers Innovations in Hematology and Oncology Basel – Novartis has been making headlines with groundbreaking data presented at major medical meetings, including the esteemed American Society of Hematology (ASH) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS). This year, Novartis is showcasing over 70 abstracts with significant findings that...

Continue Reading
Sustainable Green Team Reveals Patents for Eco-Innovation

Updated Category News Views 189

Innovative Patents by Sustainable Green Team Sustainable Green Team, Ltd. (OTC: SGTM) is making significant strides in environmental responsibility by filing an impressive portfolio of 20 U.S. provisional patent applications. This initiative marks the unveiling of the SGTM 20-Patent Fortress™, consolidating the company's dedication to revolutionizing waste management...

Continue Reading
SSL's C2PA Game Changer: Authenticity or Just Hype?

Updated Category News Views 172

SSL just dropped a bombshell on the digital content authenticity scene. On February 18, 2026, they announced themselves as the first publicly trusted certificate authority to roll out production-ready C2PA-conformant certificates. But what’s behind all this noise? Desks are buzzing about whether this marks a real breakthrough against deepfakes and misinformation or if...

Continue Reading
MiMedia's Innovations at Mobile World Congress Excite Investors

Updated Category News Views 95

MiMedia Partners with Orbic at Mobile World Congress MiMedia Holdings Ltd. is excited to announce its collaboration with Orbic, a prominent US OEM, to develop and market the new line of rugged devices under the Caterpillar brand. This partnership was highlighted during the recently attended Mobile World Congress conference, where innovative trends within the tech industry...

Continue Reading